Outcomes of combination therapy using aflibercept and dexamethasone intravitreal implant versus dexamethasone monotherapy for macular edema secondary to retinal vein occlusion

CONCLUSION: Aflibercept with dexamethasone implants achieved better visual outcomes compared to dexamethasone monotherapy with no significant differences in intravitreal retreatment rates at the 1st year in eyes with ME secondary to RVO.

Source: Middle East African Journal of Ophthalmology - April 30, 2021 Category: Opthalmology Authors: Walid Harb Georgio Chidiac Georges Harb Source Type: research